J. K. Oddershede, I. K. Meklenborg, L. Bastholt, L. M. Guldbrandt, H. Schmidt, and R. B. Friis, “Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility”, AO, vol. 64, pp. 507–515, Apr. 2025.